PL1765310T3 - Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków - Google Patents

Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków

Info

Publication number
PL1765310T3
PL1765310T3 PL05826138T PL05826138T PL1765310T3 PL 1765310 T3 PL1765310 T3 PL 1765310T3 PL 05826138 T PL05826138 T PL 05826138T PL 05826138 T PL05826138 T PL 05826138T PL 1765310 T3 PL1765310 T3 PL 1765310T3
Authority
PL
Poland
Prior art keywords
mixture
low
high molecular
transdermal administration
molecular compounds
Prior art date
Application number
PL05826138T
Other languages
English (en)
Inventor
Frederick Jordan
Geoff E Dolbear
Original Assignee
Oryxe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/017169 external-priority patent/WO2005039464A1/en
Priority claimed from US10/856,567 external-priority patent/US7220427B2/en
Application filed by Oryxe filed Critical Oryxe
Publication of PL1765310T3 publication Critical patent/PL1765310T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body
    • A61M35/003Portable hand-held applicators having means for dispensing or spreading integral media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00902Plasters containing means
    • A61F2013/00906Plasters containing means for transcutaneous or transdermal drugs application

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL05826138T 2004-05-28 2005-05-25 Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków PL1765310T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2004/017169 WO2005039464A1 (en) 2003-10-10 2004-05-28 Transdermal high and low molecular weight compounds
US10/856,567 US7220427B2 (en) 1998-07-08 2004-05-28 Mixture for transdermal delivery of low and high molecular weight compounds
EP05826138.9A EP1765310B1 (en) 2004-05-28 2005-05-25 A mixture for transdermal delivery of low and high molecular weight compounds
PCT/US2005/019017 WO2006041538A2 (en) 2004-05-28 2005-05-25 A mixture for transdermal delivery of low and high molecular weight compounds

Publications (1)

Publication Number Publication Date
PL1765310T3 true PL1765310T3 (pl) 2016-04-29

Family

ID=36148757

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05826138T PL1765310T3 (pl) 2004-05-28 2005-05-25 Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków

Country Status (4)

Country Link
EP (1) EP1765310B1 (pl)
CA (1) CA2566354C (pl)
PL (1) PL1765310T3 (pl)
WO (1) WO2006041538A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1971362T3 (en) 2005-08-19 2015-01-26 Amylin Pharmaceuticals Llc Exendin for treating diabetes and reducing body weight
US20110263496A1 (en) 2008-05-21 2011-10-27 Amylin Pharmaceuticals, Inc. Exendins to lower cholesterol and triglycerides
EP2938324B1 (en) 2012-12-31 2023-11-08 JRX Biotechnology, Inc. Liquid topical pharmaceutical nano-emulsion formulations
EP3349717A4 (en) 2015-09-17 2019-04-17 JRX Biotechnology, Inc. APPROACHES TO IMPROVE SKIN HYDROGENATION OR HUMIDIFICATION
JP7159052B2 (ja) 2016-04-08 2022-10-24 ローディア オペレーションズ パーソナルケア組成物及び該組成物の使用方法
RU2762896C2 (ru) 2016-12-20 2021-12-23 Лтс Ломанн Терапи-Систем Аг Трансдермальная терапевтическая система, содержащая азенапин
CA3047354A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
EP3644973B1 (en) 2017-06-26 2021-03-24 LTS LOHMANN Therapie-Systeme AG Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
IL277766B2 (en) * 2018-05-09 2024-12-01 Nestle Sa Composition for coating frozen confectionery and a process for manufacturing same
CN110958876B (zh) 2018-06-20 2020-12-18 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
CN112533593A (zh) 2018-06-20 2021-03-19 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
DE102021119031B4 (de) 2021-07-22 2024-08-08 Manfred Lotz Behandlung von Polymyalgia Rheumatica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829641A1 (de) * 1988-09-01 1990-03-15 Roecar Holdings Nv Transdermal anwendbare pharmazeutische zubereitungen mit sterolinen und/oder spiroketalinen
US5318960A (en) * 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
US6946144B1 (en) * 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US6656499B1 (en) * 1999-11-12 2003-12-02 Pharmaderm Laboratories, Ltd. Composition for transdermal and dermal administration of interferon-α

Also Published As

Publication number Publication date
CA2566354C (en) 2016-01-12
WO2006041538A3 (en) 2007-06-07
EP1765310A4 (en) 2012-07-04
WO2006041538A2 (en) 2006-04-20
CA2566354A1 (en) 2006-04-20
EP1765310A2 (en) 2007-03-28
EP1765310B1 (en) 2015-10-28

Similar Documents

Publication Publication Date Title
EP1799865A4 (en) PROCESS FOR THE ADMINISTRATION OF ILOPERIDONE
CY2014011I1 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
SMP200700023B (it) Dispositivi e metodi per iniezioni di medicinali
DK2292219T3 (da) Transdermalt terapeutisk system til administration af rivastigmin
ATE442131T1 (de) Stabilisierte supergesättigte feste lísungen von steroidalen arzneimitteln
LTC1761540I2 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
EP1827298A4 (en) THERAPEUTIC APPARATUS FOR IMPROVING THE PROTECTIVE EFFECTS OF POST-CONDITIONING ORGANS
DK2158905T3 (da) Sammensætning til transdermal administration af fentanyl
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
EP1891597A4 (en) UNIFIED MANAGEMENT, DISTRIBUTION, ADMINISTRATION AND IMAGING OF RADIOPHARMACEUTICAL AGENT
NO20073482L (no) Fremgangsmåte til å stabilisere antidement medikament
ECSP077238A (es) Composiciones para entrega de drogas altamente solubles en agua
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
ATE425952T1 (de) (biphenyl)carbonsauren und derivate davon
DK1701698T3 (da) Direkte komprimerbart farmaceutisk præparat til oral indgivelse af CCI-779
EP1752150A4 (en) Irinotecan PREPARATION
DK2063881T3 (da) Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer
PL1765310T3 (pl) Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków
EP1796676A4 (en) TRANSDERMALE ADMINISTRATION OF PHYCOTOXINES
GB0524958D0 (en) Transdermal administration of active agents
BRPI0720684A2 (pt) composto, medicamento, composição farmacêutica que contém e uso do composto
BRPI0912038A2 (pt) composto, mistura, composição farmacêutica, uso do composto, e, métodos para tratar e evitar uma infecção por picornavírus, e para formar o composto
SM200400022B (it) Composti farmaceutici transdermici
ATE401870T1 (de) Transdermales therapeutisches system zur verabreichung von analgetika
SE0400685D0 (sv) Means for transdermal administration of nicotine